We are monitoring the impact of COVID-19 on North America Thin Film Drugs Market Get in touch with us for detailed analysis Know More
Share on

North America Thin Film Drugs Market Research Report - Segmented By Product, Disease Indication, Distribution Channel & Country (U.S, Canada & Rest of North America) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2022 to 2027)

Published: January, 2022
ID: 6191
Pages: 145

North America Thin Film Drugs Market Size & Growth (2022 to 2027): 

As per the research report, the size of the North America Thin Film Drugs Market is valued at USD 7.83 billion in 2022 and is expected to reach USD 11.73 billion by 2027 at 8.43% CAGR during the forecast period 2022 to 2027.

A growing number of manufacturing companies are making investments based on research and development that are predicted to drive the market forward. Market growth can be explained by more widespread treatment. Technological advancements in the OTF drug market are increasing across the continent, one of the major factors driving the market upwards.

The research to develop new kinds of thin polymer films and the demand for successful drug delivery systems are factors driving the market growth. Also, the North American thin-film market is growing steadily due to funding from different government and non-profit organizations.

Because of their efficiency and efficacy, thin-film pharmaceuticals have seen a surge in popularity. As a result of the increased demand for efficient drug delivery technologies market is expected to be driven forward. In addition, patients have chosen these medications because of the ease of transit and storage. Thin-film medications also allow for exact dosing to achieve desired results, which helps the North America Thin Film Drugs Market develop.

Thin-film medications are expected to gain traction in the healthcare business because they reduce the limitations of traditional dosage forms, such as administration inconveniency, limited bioavailability, and patient non-compliance, among others. All these factors are predicted to propel the Thin Film Drugs market in North America during the forecast period.

One of the primary limitations of the market expansion is the availability of lower-cost alternatives. In addition, one of the problems impeding the market is the high cost of treatment in the thin films medicine industry.

The requirement for a significant amount of research funding and the hurdles associated with the development of new pharmaceuticals may limit the market's growth. In addition, market demand may be hampered by factors such as tight laws and norms to be followed and lengthy approval processes.

On the other hand, the difficulty of employing oral thin films in large doses might induce ulcers and mucosal irritation, limiting market expansion.

This research report on the North America Thin Film Drugs Market has been segmented and sub-segmented into the following categories:

By Product:

  • Oral Thin Film
  • Transdermal Thin Film

By Disease Indication:

  • Schizophrenia
  • Migraine
  • Opioid Dependence
  • Nausea and Vomiting

By Distribution Channel:

  • Hospital Pharmacies
  • Drug Store
  • Retail Pharmacies
  • E-Commerce

By Country:

  • U.S
  • Canada
  • Rest of North America

Geographically, the overall thin film drug market is expected to dominate North America over the forecast period. Factors contributing to market growth include:

  • The presence of key players.
  • The use of advanced technologies in pharmaceutical research and development.
  • The discovery of new drug delivery techniques.

The thin film drug market is predicted to grow due to the rising demand for effective drug delivery routes and their adequacy in the region. The market's growth is expected to be driven by government initiatives and a growing number of research partnerships.

The United States thin film drugs market dominates the thin film medicine business in North America. It is attributed to greater oral light film technology adoption and a greater focus on new product launches by regional industry participants. In addition, end-user preference for retail pharmacies, straightforward availability of a wide variety of items, and an expansion in the number of retail pharmacies in this area are all propelling the market in the United States.

The Canada thin film drugs market also dominates the market for Thin Film medicines in North America. The industry has also been boosted by increasing expenditures in the research & development of novel polymeric thin films as a medication delivery technology.

KEY MARKET PLAYERS

Companies playing a dominant role in the North America Thin Film Drugs Market profiled in this report are Pfizer Inc., Novartis AG, Wolters Kluwer, Solvay, Allergan plc., Sumitomo Dainippon Pharma Co. Ltd., Indivior Plc., MonoSol Rx, IntelGenx Corp., ZIM Laboratories Limited, and IntelGenx Corp.,

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods      

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Oral Thin Film         

                                                5.1.2.1 Sublingual Film

                                                5.1.2.2 Fully Dissolving Dental/Buccal Film

                                5.1.3 Transdermal Thin Film        

                                5.1.4 Y-o-Y Growth Analysis, By Product               

                                5.1.5 Market Attractiveness Analysis, By Product             

                                5.1.6 Market Share Analysis, By Product               

                5.2 Disease Indication                   

                                5.2.1 Introduction           

                                5.2.2 Schizophrenia        

                                5.2.3 Migraine  

                                5.2.4 Opioid Dependence            

                                5.2.5 Nausea and Vomiting         

                                5.2.6 Y-o-Y Growth Analysis, By Disease Indication           

                                5.2.7 Market Attractiveness Analysis, By Disease Indication         

                                5.2.8 Market Share Analysis, By Disease Indication          

                5.3 Distribution Channel                               

                                5.3.1 Introduction           

                                5.3.2 Hospital Pharmacies            

                                5.3.3 Drug Store               

                                5.3.4 Retail Pharmacies

                                5.3.5 E-Commerce          

                                5.3.6 Others      

                                5.3.7 Y-o-Y Growth Analysis, By Distribution Channel      

                                5.3.8  Market Attractiveness Analysis, By Distribution Channel   

                                5.3.9  Market Share Analysis, By Distribution Channel     

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By Disease Indication

                                                6.1.3.4 By Distribution Channel

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Disease Indication

                                                6.1.4.4 By Distribution Channel

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Disease Indication

                                                6.1.5.4 By Distribution Channel

                6.2 United States                            

                6.3 Canada                         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Pfizer Inc.                    

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Novartis AG                

                8.3 Wolters Kluwer                         

                8.4 Solvay                           

                8.5 Allergan plc.                               

                8.6 Sumitomo Dainippon Pharma Co. Ltd.                            

                8.7 Indivior Plc.                 

                8.8 MonoSol Rx                

                8.9 IntelGenx Corp.                        

                8.10 ZIM Laboratories Limited                   

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. North America Thin Film Drugs  Market By Product, From 2022 - 2027 ( USD Billion )
  2. North America Oral Thin Film Market By Region, From 2022 - 2027 ( USD Billion )
  3. North America Transdermal Thin Film Market By Region, From 2022 - 2027 ( USD Billion )
  4. North America Thin Film Drugs  Market By Disease Indication, From 2022 - 2027 ( USD Billion )
  5. North America Schizophrenia Market By Region, From 2022 - 2027 ( USD Billion )
  6. North America Migraine Market By Region, From 2022 - 2027 ( USD Billion )
  7. North America Opioid Dependence Market By Region, From 2022 - 2027 ( USD Billion )
  8. North America Nausea and Vomiting Market By Region, From 2022 - 2027 ( USD Billion )
  9. North America Thin Film Drugs  Market By Distribution Channel, From 2022 - 2027 ( USD Billion )
  10. North America Hospital Pharmacies Market By Region, From 2022 - 2027 ( USD Billion )
  11. North America Drug Store Market By Region, From 2022 - 2027 ( USD Billion )
  12. North America Retail Pharmacies  Market By Region, From 2022 - 2027 ( USD Billion )
  13. North America E-Commerce Market By Region, From 2022 - 2027 ( USD Billion )
  14. United States Thin Film Drugs  Market By Product, From 2022 - 2027 ( USD Billion )
  15. United States Thin Film Drugs  Market By Disease Indication, From 2022 - 2027 ( USD Billion )
  16. United States Thin Film Drugs  Market By Distribution Channel, From 2022 - 2027 ( USD Billion )
  17. Canada Thin Film Drugs  Market By Product, From 2022 - 2027 ( USD Billion )
  18. Canada Thin Film Drugs  Market By Disease Indication, From 2022 - 2027 ( USD Billion )
  19. Canada Thin Film Drugs  Market By Distribution Channel, From 2022 - 2027 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample